Evidence map›Paper›PMID 27330934›Full record

ArticleCurrent stem cell reports2016

Design Principles for Engineering of Tissues from Human Pluripotent Stem Cells.

Oriane B Matthys, Tracy A Hookway, Todd C McDevitt

Abstract read
In one paragraph

Article in Current stem cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Intestinal organoids: roadmap to the clinic.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A process engineering approach to increase organoid yield.Development (Cambridge, England) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oriane B MatthysThe Gladstone Institute of Cardiovascular Disease, San Francisco, CA; Graduate Program in Bioengineering, University of California Berkeley and University of California San Francisco, Berkeley/San Francisco, CA.
Tracy A HookwayThe Gladstone Institute of Cardiovascular Disease, San Francisco, CA.
Todd C McDevittThe Gladstone Institute of Cardiovascular Disease, San Francisco, CA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA.

Funding

UCSF/UCB Joint Graduate Group in BIoengineeringT32GM008155 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 1985 to 2020
$12.2M
Stem Cell Morphogen Delivery via Engineered BiomaterialsR01AR062006 · NIAMS · J. DAVID GLADSTONE INSTITUTES · PI MCDEVITT, TODD C · 2011 to 2015
$1.9M
NIAMS NIH HHS R01 AR062006NIGMS NIH HHS T32 GM008155
6 · The paper itself

Abstract

Recent advances in human pluripotent stem cell (hPSC) technologies have enabled the engineering of human tissue constructs for developmental studies, disease modeling, and drug screening platforms.

Indexed as

heterogeneous cell populationshuman pluripotent stem cellsmulticellular assemblyorganoidstissue architecturetissue engineering

Identifiers

PMID27330934
PMCPMC4910633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.